Skip to main content
Medicine and Pharmacy Reports logoLink to Medicine and Pharmacy Reports
. 2020 Apr 22;93(2):133–144. doi: 10.15386/mpr-1536

Current status of imaging diagnosis in the transplanted kidney. A review of the literature with a special focus on contrast-enhanced ultrasonography

Maria Ramona Bădulescu 1,, Mihai Adrian Socaciu 2, Tudor Moisoiu 3, Alexandra Andries 2,4, Gheorghiţă Iacob 5, Radu Badea 2
PMCID: PMC7243885  PMID: 32478319

Abstract

Objectives

Ultrasonographic scanning is currently the most widespread imaging diagnostic procedure. The method provides real-time morphological, vascular and elastographic information in a non-invasive manner. In recent years, harmonic vascular examination has become accessible using intravenous contrast agents. In urological pathology, this procedure is used in the detection and evaluation of vascular and ischemic complications, in the classification of complex cysts according to the Bosniak system, also in the renal lesions with uncertain etiology and in acute pyelonephritis for the detection of abscesses. The contrast agent (SonoVue) is angiospecific and can be used in patients transplanted immediately after surgery without adverse effects or impaired renal function. Thus, it is desirable to be used in the nephrological pathology of the renal graft and to develop diagnostic models based on the evaluation of renal microvascularization, as well as the quantitative data resulting from the graphical representation of the specific parameters. The purpose of this review is to evaluate the current state of the literature regarding the place and role of contrast substance ultrasound in the early diagnosis of acute renal graft dysfunction and to make a differential diagnosis of this pathological entity.

Method

This review quantifies the role of contrast ultrasound in the diagnosis of acute complications of the renal graft. The research was conducted based on the databases PubMed, MedScape, Cochrane, according to the search criteria such as contrast-enhanced ultrasound + kidney transplant, “time intensity curves” + “kidney transplant”, filtered for the period 2004–2018.

Results

In the nephrological pathology of the renal graft, contrast-enhanced ultrasound is a valuable tool, superior to Doppler ultrasound in predicting the evolution of the renal graft, identifying very small early defects in renal microvascularization. A number of studies succeeded in identifying acute graft dysfunction, some of which establish its etiology - humoral rejection versus acute tubular necrosis. On the other hand, the contrast-enhanced ultrasound parameters do not have the ability to distinguish between cellular and humoral rejection.

Conclusions

If, at present, the histopathological examination is the only one that can differentiate with certainty the cause of acute renal graft dysfunction, we consider that contrast-enhanced ultrasound, as a non-invasive imaging technique, opens a favorable perspective for increasing the survival of the renal graft and decreasing the complications in the renal transplant. The combination of other ultrasound techniques, together with contrast-enhanced ultrasound, could lead to the development of new diagnostic models.

Keywords: kidney transplantation, imaging diagnosis, acute rejection, acute tubular necrosis, acute humoral rejection, time-intensity curve, contrast-enhanced ultrasound

Preamble

Renal transplantation is a unique chance to a normal life for end-stage renal disease patients, because of the perfect morphological and functional replacement of the lost kidneys. It is also the only effective way of replacement of the endocrine function of the kidneys. Despite the immunosuppressive revolution of the ‘70s, in kidney transplant there are still events like delayed graft function (DGF) and acute rejection (AR) that are directly linked to early kidney allograft loss, if not diagnosed and treated promptly [1]. Most authors define DGF by the use of hemodialysis in the first week after the kidney transplant [2]. Acute tubular necrosis (ATN) is the most frequent cause of DGF, followed by acute humoral rejection (AHR). Because of the difference in the treatment of ATN and AHR, the correct diagnosis is essential.

Acute renal allograft dysfunction (AAD) represents the increase of serum creatinine (sCr) level more than 1.5× baseline level, and/or decrease of glomerular filtration rate (GFR) more than 25%, oliguria, and/or proteinuria more than 1 g/day [2]. There are many causes of AAD, and the differential diagnosis includes AR, urinary obstructions, bacterial and viral infections, including BK virus, vascular pathologies, calcineurin inhibitor toxicity, recurrence of primary renal disease, de novo glomerular disease, chronic allograft nephropathy. For the evaluation of kidney allograft, greyscale and Doppler ultrasonography are used routinely, being very useful in the evaluation of urologic obstruction or vascular pathologies [3]. When needed, CT scans, MRI and nuclear imaging techniques are also used [4]. Recently, reports are describing the use of contrast-enhanced ultrasonography (CEUS) as the diagnostic test for AAD.

This review intends to present an update of the use of CEUS as a diagnostic tool for AAD and differential diagnosis of different allograft pathologies.

Invasive and noninvasive (non-ultrasonographic) morphological diagnosis of renal graft dysfunction

a. Kidney biopsy

The morphological diagnosis of graft dysfunction can be made only by allograft biopsy, which is an invasive method. Non-invasive techniques like the US, CT, and MRI may have a complementary role.

After the exclusion of urologic and vascular causes of allograft dysfunction (AD), the workup protocols recommend having an allograft biopsy, a procedure with many possible complications such as bleeding and arterial-venous fistulae [58]. It is also time-consuming and has interobserver variabilities. The pathology evaluation of the allograft biopsy is made using the Banff classification, which evaluates the morphology of all renal compartments (glomerules, tubules, arteries and capillaries, and interstitium). The inflammatory involvement of the arteries, arterioles, and peritubular capillaries are a key target for the CEUS evaluation. The acute modifications are characterized by cellular or humoral inflammatory pathway activation. The chronic modifications are represented by intimal hyperplasia, arteriolar hyalinization, and the splitting of the tubules basal membrane [9]. ATN and AHR have many common morphological aspects, such as the lesions of the tubular epithelial cells or the inflammation of peritubular cells. For the differentiation, immunochemistry staining is used. It is good to mention that the allograft biopsy is still the gold standard for the diagnosis of ATN and AHR [10,11].

b. Non-ultrasonographic, sectional, and functional imaging explorations

As mentioned above, there are other imaging evaluation methods used in the workup of AAD like CT scans, MRI, and single-photon emission computed tomography (SPECT).

The magnetic resonance imaging (MRI)

MRI has the advantage of using no radiation and analyzing the morphology of the tissue in many sequences like T1 and T2 [12]. MRI can evaluate many aspects of the allograft kidney like renal perfusion, oxygenation, and inflammation [13]. MRI elastography can evaluate the fibrosis level of the allograft but with no information regarding its functional status [14]. There is no study published until now to evaluate the sensitivity and specificity of MRI in the diagnosis of AD. The lack of interest in the use of MRI in the workup of AD is because of the risk of Gadolinium renal toxicity which, in extreme cases, can lead to systemic nephrogenic fibrosis in a patient with renal insufficiency or chronic hemodialysis [15].

Computed Tomography (CT)

CT scan is also used in the workup of AD, but again, because of the nephrotoxicity of the contrast agent, it is less used [15].

Single-photon emission computed tomography (SPECT)

It is a conventional nuclear imaging technique that is used for the assessment of the allograft function.

Positron emission tomography-computed tomography (PET-CT)

It uses glucose analogs functionalized with radioisotopes in order to evaluate the cellular metabolism of different tissues. The technique is done in a “whole body” manner [16], and it has a sensitivity of 100% and specificity of 50% in the diagnosis of AR [17]. The disadvantage of the isotopic techniques is the irradiation, while the benefit is the high sensitivity and the operator-independent interpretation.

Ultrasonographic diagnosis

Current ultrasonography (US) evaluation techniques can evaluate the morphology and vascular status of the allograft with the greyscale US, color Doppler and CEUS. These techniques are noninvasive, well tolerated by the patient, and can provide complex information about the status of the allograft, being also relatively reproducible. A great advantage for the use of the US is the position of the allograft in the iliac fossa that offers a perfect visualization of the kidney with no interference of other organs.

a. “Gray scale” ultrasonography

The US provides morphological details of the allograft, such as position, form, and relationships with neighboring organs (Figure 1). It can differentiate the two components of the renal parenchyma (cortex and medulla), and it can evaluate the functionality of the allograft. US criteria for the diagnosis of AD are allograft enlargement, hyperechogenic cortex and hypoechogenic medulla with the unclear delimitation of the two structures [1820]. In AD, liquid collections may appear surrounding the allograft or the nearby organs, US being able to diagnose even small accumulation of liquid [21]. It is worth mentioning the possibility of the newest US machines to detect and characterize blood flow in medium to small vessels in the allograft.

Figure 1.

Figure 1

Grey-scale ultrasonographic appearance of a renal graft located in the right iliac fossa. The image quality is superior to the ultrasonographic appearance of the kidney in its native (lumbar) position due to the superficial position of the organ. The kidney appears as an oval structure where in the periphery there is the parenchyma (with more hypo-echogenic areas corresponding to the medulla) and in the center the hyper-echogenic appearance of the pyelocalyceal system.

There are two ultrasonographic vascular modes that use different technologies and principles: Doppler and CEUS. Both modes are presenting the “real-time” situation of the blood flow in a specific part of the allograft called the region of interest (ROI). Both techniques are operator dependent. The main differences regarding Doppler vs CEUS are the need for additional acquisition of the program and the need for a large band transducer (see Tables I and II).

Table I.

Vascular explorations using the Doppler and CEUS ultrasound techniques. Similarities.

vascular investigations
non-invasive explorations
“real-time” information
focused on limited regions (ROI)
information: qualitative + quantitative
procedures “included” in the current ultrasound examination
very good temporal resolution (pre-time)
the decision to make belongs to the examining physician
clinically integrated explorations
requires training
requires continuous practice
dependent operator

Table II.

Vascular explorations using the Doppler and CEUS ultrasound techniques. Differences.

Criteria Doppler CEUS
Principles of the method vectorial information;
shows the flow speed and blood flow direction;
the source of the echoes - groups of red blood cells;
delivered ultrasound information – specific located (Doppler sample positioned in the middle of the vessel)
harmonic information
evaluation of the contrast agent transit through the circulatory bed
echoes types: harmonic
echoes source - microbubbles information delivered - regional (all field)
Sensitivity limited to 2 cm/sec independent of blood movement
Technology integrated equipment additional
soft + AC + broadband transducer
The error factors (related method) insonation angle (<60 degrees)
the size of the sample collection area
PRF
attenuation
the number and position of the outbreak
IM
Vessels explored arteries and veins
medium and large trunks
microcirculation: indirect (IP. IR, S/D)
arteries
medium and large trunks
microcirculation
Information obtained speed (cm/sec)
flow type (pulsatility);
sense of movement
movement pattern (laminar, turbulent);
characteristics of blood transit through ROI
the total and partial flow duration (sec)
microvascular exploration
Dependence of the quality image in grey scale partial total
Dependence on depth partial partial

b. Doppler vascular ultrasonography

Due to the superficial position of the renal graft in the iliac fossa, as well as the easy visualization of the anastomosis of the renal vessels with the iliac vessels, Doppler ultrasound is widely used in the kidney transplant, being accessible both in the operating room and at the patient’s bed.

It helps in early diagnosis of large and medium vessel complications, allowing reintervention and thus the saving of the renal graft [22]. Therefore events like renal artery and vein thrombosis, renal artery stenosis, renal infarcts, aneurysms, and arteriovenous fistula are frequently and easily diagnosed thanks to Doppler ultrasound [3].

On the other hand, the diagnosis of acute and chronic rejection involves pathological changes, that affect peritubular and glomerular capillaries, type of vessels at which Doppler ultrasound cannot quantify directly hemodynamic parameters [23].

Doppler mode can be color and power, offering valuable information regarding intrarenal vasculature. Color Doppler mode can present the vascular status of a certain area, whereas power Doppler mode is focused on the single blood vessel, these two techniques being complementary (Figure 2). The Doppler mode offers information regarding the presence of blood flow, distribution, pulsatility, and amplitude of the allograft vasculature. Also, it can measure the blood flow speed in cm/sec. The ratio between systolic and diastolic velocities is called impedance indices (resistivity - RI; pulsatility - PI; systolic diastolic ratio - S/D) and correlates with the quality of the parenchymal circulatory bed [24].

Figure 2.

Figure 2

Ultrasonographic appearance in color Doppler mode of a transplanted kidney. The presence of the circulatory signal starting from the renal hilum and ending with the arch arteries, in subcapsular position, is noticed. The red and blue coloring of the signal is a convention; the color being directly correlated with the direction of movement of the blood column relative to the transducer.

Impedance indices are measured at the level of the interlobular and arched arteries representing an indirect assessment of renal microcirculation (Figure 3). Cano et al. have shown that RI is a useful marker in evaluating post-transplant renal function, so that an increase of more than 0.7 raises the suspicion of acute renal graft dysfunction, but without distinguishing between AR, ATN, toxicity to inhibitors calcineurin, renal vein thrombosis, ureteral obstruction or acute pyelonephritis [25].

Figure 3.

Figure 3

Spectral Doppler ultrasound aspect of a blood flow passing through main artery of a kidney graft. The systolic-diastolic waveform may be noticed – where the minimum speed is upper to the 0 line – suggesting a low resistance circulatory bed. The laminar flow can be seen by placing the velocity vectors in the upper area of the curve. The distribution of vectors above line 0 suggests oriented flow transducer.

Several researchers have shown that RI and PI measured immediately after transplantation predict long-term renal graft outcome [2629]. More than that, the vascular resistivity index measured by Doppler ultrasound is correlated with the resistivity index recorded by the life-port perfusion machine used for kidney preservation. It may predict the primary graft outcome [30]. Seiler et al. measured resistivity index in different organs of the transplanted patient, including the renal graft, and concluded that RI indicates the presence of systemic vascular pathology, predicting mortality rather than renal graft dysfunction [31], being affected by pulse pressure, frequency and heart rate [32].

In the same manner, Heine and co-workers found an increased RI associated with subclinical systemic atherosclerosis, the pulse pressure, age over 60 years, female sex, and the presence of diabetes. They did not find any correlation between RI and GFR or RI and the age of the donor [33].

c. Harmonic vascular ultrasonography using i.v. contrast agents - CEUS

Initially, CEUS was used in liver pathology, later proving its usefulness in the evaluation of renal graft. The elements that recommend the exploration of CEUS in renal graft pathology are the superficial position of the graft, the lack of irradiation and the toxicity of the contrast substance, the repeatability of the method, as well as the ease of performing the method at the patient’s bed. The contrast agent currently used in the EU is called SonoVue® (Bracco, Italy). It contains sulfur hexafluoride functionalized microbubbles having a phospholipid membrane (eliminated predominantly by the respiratory tract) that are small enough (about 2.5 μm) to penetrate the renal microcirculation without subsequently entering the renal interstitium. The administration of SonoVue has minimal risk to the patient [34,35]. SonoVue® is insoluble in water or body fluids so that once it reaches the blood, it reflects the ultrasound (the acoustic impedance of the microbubbles is about 25 dB greater than that of the blood) in the form of harmonic echoes, giving it a more hyper-echogenic appearance compared to that of adjacent tissues [36]. The microbubbles break when using a mechanical index that is too high (usually >0.5). Therefore a mechanical index of 0.1 or less is required. After the intravenous administration of SonoVue, the procedure is recorded for 3–4 minutes.

The analysis of the CEUS procedure has three components: observational, quantitative, and semi-quantitative.

1. Observational analysis

It consists of dynamic exploration using two ultrasonographic fields (one that gives fundamental echoes, another that gives harmonic echoes) and the evaluation of the loading times of the circulating bed for the total duration of the exploration. After administration of the contrast substance, three phases can be identified:

  1. early arterial phase in which the arteries are visualized, observing the progression of the contrast substance at the level of the iliac artery, the renal artery, the interlobular artery, the interlobular arteries, and then the arched arteries (first 20 seconds);

  2. delayed arterial phase (or cortical phase) - lasts approx. 20–40 seconds and in this phase the contrast agent is uniformly captured in the renal cortex with a clear cortico-medullary differentiation;

  3. the medullary phase (also called nephrographic) can be followed for 40–120 sec after the injection of the contrast substance. In this phase, there is a gradual loading of the contrast agent at the level of the Malpighi pyramids until the cortex and medulla have equal amounts of contrast agent. The disappearance of the contrast agent from the kidney usually occurs after 2 minutes, but sometimes it can persist for up to 4–5 minutes (Figures 4a, 4b and 4c).

Figure 4a.

Figure 4a

Early arterial phase (<20 sec). On the left: the image created by fundamental echoes. On the right: the harmonic, vascular image. To notice the enhance at the level of the segmental arteries followed by the arcuate arteries.

Figure 4b.

Figure 4b

Delayed arterial phase (or cortical phase) - lasts approx. 20 – 40 seconds. On the right image it is noticed the full enhancement of the cortical parenchyma; Accentuated hypoechoic aspect of the medulla may suggest the wrong appearance of renal cyst.

Figure 4c.

Figure 4c

The medullary phase (also called nephrographic) can be followed for 40 – 120 sec after the contrast administration. In this phase, the contrast agent is uniformly captured in the renal parenchyma.

2. Quantitative analysis

The quantitative CEUS exploration is a distinct component, obtained by refining stored temporal information. The analysis is focused on the dynamics of the transit of the contrast agent through ROI and aims to measure perfusion parameters related to the circulatory bed. Besides the advantage of representing certain hemodynamic phenomena through graphical information (“time-intensity curves”), it also allows their numerical analysis in comparison with other regions considered by reference (normal or with different types of pathologies).

The visual representation of the variation of the signal intensity over time is called the “time-intensity curve” (TIC). There is a direct correlation between the characteristics of the curve and the peculiarities of the circulating bed. By applying a mathematical model that describes the curves, one can obtain numerical information called TIC parameters, such as: the contrast agent transit rate through ROI (WiR - “wash in rates”); peak height (PE - “peak enhancement”), area under the curve (WiAUC - “area under the curve during wash in”), peak time (TTP - “time to peak”), rise time (RT - “rise time”) or the average transit time (mTTl - “medium transit time, local”). Measurements are made either after the bolus injection of the contrast agent (non-cardiac applications, only once) or after continuous administration of it in the form of infusion (cardiologic applications, several times, each measurement being preceded by the bursting of the bubbles generated by the increase of IM at high values, over 0.5). The limits of the procedure are represented by the variability of the harmonic signals, depending on the equipment used and not the standardization of the information collection mode. The advantages of the method are good accuracy, noninvasiveness and lack of irradiation, possibility of repetition whenever necessary, relatively low costs and reproducibility. The large number of parameters that can be studied makes this application a valuable tool for research in various medical areas [37].

The TIC analysis can be performed after the patient has left the medical office, being performed offline. The curves are generated at the level of samples (round, rectangular, or “freehand”) set by the examiner related to ROI from different areas of the kidney. At the level of each sample, the ultrasonographic equipment will represent on the screen functions of the signal intensity variation (in dB or acoustic units - a.u.) over time. Following the calculations made by the program, the time of entry and the total duration of the contrast agent transit through ROI, the time of systolic ascension, the time of unloading, the area under the curve will be recorded (Figure 5).

Figure 5.

Figure 5

Quantitative analysis of the contrast passage mode in different anatomical regions at of the renal graft.

3. Semi-quantitative analysis

The semi-quantitative analysis consists of the superimposition of a color map over the ultrasound image, through which temporal information from a whole contrasting examination loop is connected. The analysis allows the assessment of a static image of some dynamic elements, such as the direction and the speed of capture in different regions of the image. It is necessary to select a time duration for the moment when the contrast agent becomes visible in the circulatory bed of the graft and to select the “parametric” application. The equipment will automatically represent in different colors the sequence of filling the circulatory bed (Figure 6).

Figure 6.

Figure 6

Parametric, semi-quantitative analysis of the contrast passage mode at the level of the circulatory bed in a limited time. Each moment of penetration of the contrast agent has a different color representation.

The guide for non-hepatic applications of the European Federation of Ultrasonography Societies in Medicine and Biology (EFSUMB) 2017 recommends the use of CEUS in renal transplantation for vascular and ischemic complications of the renal graft, characterization of complex cysts - according to the Bosniak classification, in undetermined renal injury, as well as and in acute pyelonephritis. The guide concludes that quantitative functional information resulting from the use of the TIC curve may reveal altered renal microperfusion, but requires further investigation in large batches of patients in order to understand the importance of these changes in transplanted kidney pathology [38].

Intravenous contrast harmonic ultrasono-graphy in the evaluation of the renal graft

a. CEUS parameters correlate with renal function

The CEUS parameters are correlated with the renal function, a fact initially demonstrated by the Italian team formed by Farina and collaborators. They enrolled 56 kidney transplant patients in the study, explored by CEUS using a 1st generation Levovist contrast agent, and noted that slow loading time and delayed washout were associated with graft dysfunction and reduced renal function. At the same time, they observed an inversely proportional variation of the TTP values depending on the creatinine clearance (ClCr). Thus in the group with chronic rejection, there was a ClCr of approx. 28–42 ml / min and a TTP=235 sec. In the group with ATN a ClCr=32–60 ml/min TTP=130 sec was found. At the same time the control group had a ClCr=92–112 ml/min and TTP <65 sec. [39]. Wang and co-workers have shown that CEUS examination expresses quite precisely the microcirculatory characteristics of renal parenchyma, and a correlation between the value of the parameters of this examination and the renal function can be established. The grafts that had dysfunction required a longer loading time with the contrast substance both in the renal cortex and in the renal medulla. There were statistically significant differences between the group with normal and abnormal kidney function transplanted with lower values of the slope of the ascending cortex at the cortical level (A1 - 1.27±0.57) and that at the medullary level (A2 - 0.87±0.42). They also found a lower value of maximal intensity (DPI1 - 7.45±3.38) in the group of patients with graft dysfunction versus the group without dysfunction (A1 - 1.79±0.59 sec; A2 - 1.24±0.50 sec DPI1 - 9.75±1.65 sec) [40].

b. CEUS examination identifies early AD microcirculatory changes

Renal biopsy and histopathological examination led to a better understanding of the pathophysiology of these entities, but this method is burdened with numerous risks. Over time, Doppler ultrasound was introduced, which, using indirect evaluation like spectral Doppler with the help of RI, PI and S/D parameters of microcirculation resistance, could raise the suspicion of AAD due to the immunological cause. More recent studies have shown, however, that the impedance indices mentioned have good sensitivity but low specificity [25]. Under these conditions, there was a need to find new diagnostic methods with minimal risks for both the patient and the kidney graft. Currently, the use of CEUS in renal transplantation refers to the urological pathology of renal graft [38]. However, its role in nephrological pathology (AR, ATN) is a promising one [41], the general desire being to develop diagnostic models based on micro vascularization of the renal graft to avoid unnecessary biopsies of the transplanted kidney. A first study addressing the value of CEUS examination in the immediate post-transplant period was conducted by Fischer et al. in 2004 on 18 patients, noting that the quantitative parameters used in contrast ultrasound can identify early acute rejection prior to RI modification. Patients were evaluated with the US in both B and Doppler mode, respectively CEUS, at 5 and 6 days post-transplant. The authors demonstrated that in the rejection group (6 patients), the TIC curve revealed a delay in the progression of the contrast substance in the subcapsular area (TTP of 32.9±8.3 sec) and a less pronounced cortical intensity (3.8±2.3 μl/sec) compared to that of the renal artery (7.9±50.9 μl/sec) and interlobular arteries (8.7±3.8 μl/sec) respectively. On the other hand, in the non-rejection group (6 patients) the TIC curve had a rapid and abrupt increase (TTP 20.9±4.7 sec). The intensity of the harmonic signal of the contrast substance was similar in the renal artery (11.7±4.5 iu/sec), the interlobular artery (8.7±4.6 iu/sec) and the subcapsular region (8.3±3.7 iu/sec) [42] (Figures 7 and 8).

Figure 7.

Figure 7

Time intensity curve (TIC) in case of acute rejection renal parenchyma. A delay in the wash-in and wash-out can be observed.

Figure 8.

Figure 8

Time intensity curve (TIC) in case of normal renal graft parenchyma. A fast wash-in and wash-out can be observed (the outflow slope is “sharp”).

c. CEUS allows discrimination between graft dysfunction and normal renal function

Grzelak et al. performed a study on 63 patients (35 with stable renal function and 28 with AAD) and analyzed CEUS and Doppler parameters at 70–120 h post-transplant. They found that AAD patients had a statistically significant delay in the progression of the contrast substance in the areas of interest. The mean contrast agent uptake time in the renal cortex versus the segmental arteries was 2.35±0.69s in RA, 2.08±0.69s in ATN, respectively 0.92±0.53s in the group with stable renal function. At the level of the renal pyramids, the mean contrast agent uptake time was 3.25±0.81s in RA; 3.03±0.81s in ATN; respectively 1.2±0.62 s in the group with stable renal function. The use of CEUS better distinguishes the group of patients with renal dysfunction from that of normal function, compared with the use of impedance indices (RI, PI, S/D) in Doppler ultrasound. A delay of more than 2 seconds in the capture of the contrast substance strongly suggests a renal graft dysfunction [43].

d. CEUS examination allows an etiological diagnosis of graft dysfunction

The lack of clinical signs or specific laboratory values makes the differential diagnosis between ATN and RA more difficult. At present, the differentiation can be done only with the help of histopathological examination, the development of new diagnostic models based on the evaluation of renal microcirculation being desirable.

Fischer et al. re-evaluated the efficiency of the contrast ultrasound technique in a batch of 32 patients during the first 5–7 days after transplantation. Patients were divided into 3 subgroups: acute rejection (n-7); perirenal hematoma (n-6); non-rejection (with retained renal function, n-17). It was observed that in the group of patients with a perirenal hematoma the loading with the contrast substance was heterogeneous, helping to delimit the hematoma, but its intensity in the renal cortex (9.2±3.8 dB/sec) was lower compared to that of the renal artery (15.3±6.3 dB/sec) [44].

In the patients with rejection the intensity of contrast in the renal cortex (7.4±3.2 dB/sec vs. 10.3±4.3 dB/sec in the non-rejection group) was lower than in the renal artery (10.7±4.3 dB/sec vs. 12.5±5.5 dB/sec), and the temporal difference seen graphically between the subcortical area and the renal artery was greater in the rejection group (Δt=2.27±0.73 sec) versus the non-rejection group (Δt=0.97±0.62 sec) [44].

The same group of researchers led by Thomas Fischer evaluated 48 patients at 4–10 days after transplant. The authors defined the “infusion coefficient” (PQ) as the ratio of filling time in the interlobular artery and the renal cortex. This parameter showed double values in the vascular rejection group (n=5) (2.2±0.8) compared to the control group (1.2±0.4) (n=19). At the same time, patients with ATN (n=7) and those with perirenal hematoma (n=7) had higher values of the infusion coefficient (1.6±0.7), respectively (1.7±0.4) compared to the control group. Patients with non-vascular rejection (7) had similar TIC curve values as those in the control group [45].

Fischer and colleagues subsequently tried to develop a standardized tool for the diagnosis of acute rejection. The study included 12 patients in the non-rejection group, 8 patients with rejection, and 2 patients with perirenal hematoma. The time elapsed until the first increase in signal intensity in the renal artery and the renal cortex was calculated, determining the difference between the two values. This time difference was higher in the rejection group (2.2±0.7 sec) than in the control group (p<0.05). Also, as in the first studies, an increase in the time difference was also identified in the two patients who had a perirenal hematoma. Patients were examined at 6 days post-transplant both with contrast and conventional ultrasonography, measuring volume and impedance indices (RI, PI, S/D) giving uncertain results [46].

Benozzi and colleagues performed a study on 39 patients in the first 30 days after transplantation. They were examined in Doppler mode and by CEUS technique. With the help of the first ultrasound method, the increase of the resistivity indices led to the identification of the patients with AAD but did not provide information to differentiate the AR from the ATN. When examining by CEUS, an increased value of TTP was observed in the group of patients with AR compared to those in the control group. Also, in patients with ATN, the infusion ratio between medullary and cortical (RBV) was <0.81 and the mTT (mean transit time) between medullary and cortical was <0.87, both values lower than those of the control group [47].

The usefulness of the CEUS method in the diagnosis of RA has been demonstrated by a group of Chinese researchers by describing a high sensitivity and specificity. They enrolled 57 patients in the study who were followed for an average of 20 months after transplantation. A number of indicators were identified: RT and TTP at the medullary level (RTm/TTPm) and the interlobular artery (RTi/TTPi), as well as the difference of the same parameters between medullary and cortical (Δ RTm-c and Δ TTPm-c), which were statistically significantly higher in patients with acute rejection than in the control group. In addition, RTm, TTPm, Δ RTm-c, and Δ TTPm-c were significantly higher in AR patients than in ATN patients. The IR level in patients with ATN was higher than in the healthy ones, but without any increase in the acute rejection group [48].

Regarding the differential diagnosis of AD, Fernandez and collaborators performed a study on five patients who subsequently required emergency nephrectomy in which the histopathological diagnosis was acute cortical necrosis. They showed renal artery loading followed by renal pyramidal loading, with a defect in the cortical banding, which is comparable to that identified in CT and MRI [49].

e. The exploration of CEUS allows anticipating the evolution of the renal function in the transplanted patient

This will help the nephrologist to more closely monitor and individualize the immunosuppressive therapeutic plan in patients at risk. The vigilant attitude translates into early treatment and an increase in the survival of the renal graft. Kay et al. conducted a pilot study that aimed to specify the prognostic value of contrast substance use on ultrasound in the immediate post-transplant period, proving that CEUS is reproducible and has prognostic value. Thus the “area under the curve” determined in the first week after transplantation was correlated with renal function at three months [50]. The prognostic value of CEUS was also demonstrated by Schwenger et al., who evaluated CEUS and Doppler at seven days and one year after transplantation in a group of 68 patients. It has been observed that the values of renal blood flow measured with the help of CEUS in the first week after transplantation correlates with the renal function at one year and with the age of the donor, and among the values of the histopathological scores corresponding to the Banff classification are correlated with the intimal fibrous thickening. Also, the resistivity index was correlated with the age and the vascular compliance of the recipient [51].

Mori et al. performed research on a group of 39 transplanted patients that he followed for four years, observing a decrease in the rate of glomerular filtration in the first year but maintaining the same values for the next 3 years. CEUS parameters represented by mean transit time (MTT), cortical blood flow (cRBF) and regional blood volume (RBV) were positively correlated with glomerular filtration rate and medullary blood flow (mRBF) was negatively correlated. A good cortical renal perfusion immediately after transplant can predict a favorable evolution of the graft in the following years. It was concluded that the Doppler examination has a high sensitivity in terms of graft dysfunction, and CEUS has increased specificity in relation to the renal parenchyma infusion rate, the two examinations combined providing promising long-term prospects [52].

A recent study, conducted by Stenberg, has managed to identify, using CEUS, infusion defects of up to 0.2% of total renal volume, which have been detected in a large number of patients (20 out of 99 patients). The extent of these non-perfused regions correlated with renal function at 1 month and 3 months post-transplant [53].

f. CEUS examination is superimposed on renal graft biopsy in well-defined situations

Currently, researchers are looking for ways to replace biopsy by numerous non-invasive diagnostic procedures. In this regard, Muller-Peltzer et al. tried to analyze the parameters of the diagnostic test for CEUS compared with renal biopsy. They noted a sensitivity of 85.7%, specificity of 100%, a positive predictive value of 100% and a negative predictive value of 98%. The study analyzed 57 patients with impaired renal function, of whom 7 had acute vascular rejection. CEUS was able to identify 6 of the 7 cases, but could not differentiate the histological subtypes of rejection (cellular versus humoral) [54].

Conclusions

After proving its diagnostic qualities in liver pathology [55], CEUS extends its applicability to other parenchymal organs as well, the transplanted kidney being one of the most recently studied organs with this technique. Different specialized centers evaluated the characteristic parameters of CEUS at the level of renal graft, comparing the results obtained with those of other rejection diagnostic techniques. Most studies have shown a delay in capturing the contrast agent and a lower intensity in the areas of interest in both acute graft dysfunction, acute and chronic rejection, acute tubular necrosis, and large perirenal hematoma.

Compression of hematoma or interstitial edema from acute tubular necrosis on the vascular bed could explain the changes observed with the help of CEUS in these pathologies. The reduction of cortical perfusion, evidenced by the CEUS technique, would indicate the reduction of GFR [52] and the presence of acute rejection [44]. These data are in accordance with the study of Sis et al. [56] who demonstrated that lesions specific to acute rejection initially occur in the renal cortical area. At the current level of knowledge, CEUS is useful in the evaluation of renal micro vascularization, being able to identify small defects up to 0.02 of the total renal volume [53] which could not be detected with the help of the Doppler. Also, a good renal infusion discovered immediately after transplantation can predict a favorable evolution of the graft in the long term [52]. However, in order to develop diagnostic models based on renal graft micro vascularization, studies are needed on larger groups of patients. It is important to note that chronic changes like fibrosis, intimal arterial hyperplasia, and glomerulosclerosis can cause alterations in renal micro vascularization. Probably, in the future, together with CEUS, other methods of ultrasound evaluation, such as elastography, will contribute to increasing the specificity of the diagnosis of renal graft pathologies. At present, CEUS cannot differentiate between the cellular and humoral rejection [45,54]. The histopathological examination is still the gold standard of diagnosis. CEUS has also proven its effectiveness in identifying vascular rejection, a pathological entity diagnosed with the help of this imaging technique by several teams of researchers [45,46,54].

Acknowledgments

This work was supported by a grant of Ministery of Research and Innovation, CNCSIS - UEFISCDI, project number PN-III-P4-ID-PCE-2016-0701, PNCDI III contract number: 184 / 2017.

References

  • 1.Lim WH, Johnson DW, Teixeira-Pinto A, Wong G. Association between duration of delayed graft function, acute rejection, and allograft outcome after deceased donor kidney transplantation. Transplantation. 2019;103:412–419. doi: 10.1097/TP.0000000000002275. [DOI] [PubMed] [Google Scholar]
  • 2.Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Kidney Disease: Improving GlobalOutcomes (KDIGO) Transplant Work Group. Am J Transplant. 2009;9(Suppl 3):S1–S155. doi: 10.1111/j.1600-6143.2009.02834.x. [DOI] [PubMed] [Google Scholar]
  • 3.Granata A, Clementi S, Londrino F, Romano G, Veroux M, Fiorini F, et al. Renal transplant vascular complications: the role of Doppler ultrasound. J Ultrasound. 2014;18:101–107. doi: 10.1007/s40477-014-0085-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Köhnke R, Kentrup D, Schütte-Nütgen K, Schäfers M, Schnöckel U, Hoerr V, et al. Update on imaging-based diagnosis of acute renal allograft rejection. Am J Nucl Med Mol Imaging. 2019;9:110–126. [PMC free article] [PubMed] [Google Scholar]
  • 5.Redfield RR, McCune KR, Rao A, Sadowski E, Hanson M, Kolterman AJ, et al. Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy. Transpl Int. 2016;29:167–172. doi: 10.1111/tri.12660. [DOI] [PubMed] [Google Scholar]
  • 6.Reschen ME, Mazzella A, Sharples E. A retrospective analysis of the utility and safety of kidney transplant biopsies by nephrology trainees and consultants. Ann Med Surg (Lond) 2018;28:6–10. doi: 10.1016/j.amsu.2018.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tapia-Canelas C, Zometa R, López-Oliva MO, Jiménez C, Rivas B, Escuin F, et al. Complications associated with renal graft biopsy in transplant patients. Nefrologia. 2014;34:115–119. doi: 10.3265/Nefrologia.pre2013.Nov.12232. [DOI] [PubMed] [Google Scholar]
  • 8.Tsai SF, Chen CH, Shu KH, Cheng CH, Yu TM, Chuang YW, et al. Current safety of renal allograft biopsy with indication in adult recipients: an observational study. Medicine (Baltimore) 2016;95:e2816. doi: 10.1097/MD.0000000000002816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293–307. doi: 10.1111/ajt.14625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Williams WW, Taheri D, Tolkoff-Rubin N, Colvin RB. Clinical role of the renal transplant biopsy. Nat Rev Nephrol. 2012;8:110–121. doi: 10.1038/nrneph.2011.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Broecker V, Mengel M. The significance of histological diagnosis in renal allograft biopsies in 2014. Transpl Int. 2015;28:136–143. doi: 10.1111/tri.12446. [DOI] [PubMed] [Google Scholar]
  • 12.Zhang JL, Morrell G, Rusinek H, Sigmund EE, Chandarana H, Lerman LO, et al. New magnetic resonance imaging methods in nephrology. Kidney Int. 2014;85:768–778. doi: 10.1038/ki.2013.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.van Eijs MJM, van Zuilen AD, de Boer A, Froeling M, Nguyen TQ, Joles JA, et al. Innovative perspective: gadolinium-free magnetic resonance imaging in long-term follow-up after kidney transplantation. Front Physiol. 2017;8:296. doi: 10.3389/fphys.2017.00296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sarvazyan A, Hall TJ, Urban MW, Fatemi M, Aglyamov SR, Garra BS. An overview of elastography - an emerging branch of medical imaging. Curr Med Imaging Rev. 2011;7:255–282. doi: 10.2174/157340511798038684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hanssen O, Erpicum P, Lovinfosse P, Meunier P, Weekers L, Tshibanda L, et al. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clin Kidney J. 2017;10:97–105. doi: 10.1093/ckj/sfw062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Mazière B. FDG accumulation and tumor biology. Nucl Med Biol. 1998;25:317–322. doi: 10.1016/s0969-8051(97)00226-6. [DOI] [PubMed] [Google Scholar]
  • 17.Lovinfosse P, Weekers L, Bonvoisin C, Bovy C, Grosch S, Krzesinski JM, et al. Fluorodeoxyglucose F(18) positron emission tomography coupled with computed tomography in suspected acute renal allograft rejection. Am J Transplant. 2016;16:310–316. doi: 10.1111/ajt.13429. [DOI] [PubMed] [Google Scholar]
  • 18.Krejci K, Zadrazil J, Tichý T, Al-Jabry S, Horcicka V, Strebl P, et al. Sonographic findings in borderline changes and subclinical acute renal allograft rejection. Eur J Radiol. 2009;71:288–295. doi: 10.1016/j.ejrad.2008.04.021. [DOI] [PubMed] [Google Scholar]
  • 19.Yazdani M, Ghaemian N, Khafri S, Oliaei F. Can the kidney volume help to differentiate the types of rejection before biopsy? Caspian J Intern Med. 2019;10:11–15. doi: 10.22088/cjim.10.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Park SB, Kim JK, Cho KS. Complications of renal transplantation: ultrasonographic evaluation. J Ultrasound Med. 2007;26:615–633. doi: 10.7863/jum.2007.26.5.615. [DOI] [PubMed] [Google Scholar]
  • 21.Richard HM. Perirenal transplant fluid collections. Semin Intervent Radiol. 2004;21:235–237. doi: 10.1055/s-2004-861557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Horrow MM, Parsikia A, Zaki R, Ortiz J. Immediate postoperative sonography of renal transplants: vascular findings and outcomes. AJR Am J Roentgenol. 2013;201:W479–W486. doi: 10.2214/AJR.12.10310. [DOI] [PubMed] [Google Scholar]
  • 23.Zeisbrich M, Kihm LP, Drüschler F, Zeier M, Schwenger V. When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation? Clin Kidney J. 2015;8:606–614. doi: 10.1093/ckj/sfv070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Meier M, Fricke L, Eikenbusch K, Smith E, Kramer J, Lehnert H, et al. The serial duplex index improves differential diagnosis of acute renal transplant dysfunction. J Ultrasound Med. 2017;36:1607–1615. doi: 10.7863/ultra.16.07032. [DOI] [PubMed] [Google Scholar]
  • 25.Cano H, Castañeda DA, Patiño N, Pérez HC, Sánchez M, Lozano E, et al. Resistance index measured by Doppler ultrasound as a predictor of graft function after kidney transplantation. Transplant Proc. 2014;46:2972–2974. doi: 10.1016/j.transproceed.2014.07.001. [DOI] [PubMed] [Google Scholar]
  • 26.Buturovic-Ponikvar J, Cerne S, Arnol M, Kandus A, Ponikvar R, Bren A. Early kidney graft size and Doppler parameters are associated with kidney graft function 1 year after transplantation. Transplant Proc. 2010;42:4026–4029. doi: 10.1016/j.transproceed.2010.09.053. [DOI] [PubMed] [Google Scholar]
  • 27.Barba J, Rioja J, Robles JE, Rincón A, Rosell D, Zudaire JJ, et al. Immediate renal Doppler ultrasonography findings (<24 h) and its association with graft survival. World J Urol. 2011;29:547–553. doi: 10.1007/s00345-011-0666-3. [DOI] [PubMed] [Google Scholar]
  • 28.Adibi A, Ramezani M, Mortazavi M, Taheri S. Color Doppler indexes in early phase after kidney transplantation and their association with kidney function on six month follow up. Adv Biomed Res. 2012;1:62. doi: 10.4103/2277-9175.100184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Enhesari A, Mardpour S, Makki Z, Mardpour S. Early ultrasound assessment of renal transplantation as the valuable biomarker of long lasting graft survival: a cross-sectional study. Iran J Radiol. 2014;11:e11492. doi: 10.5812/iranjradiol.11492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Elec FI, Lucan C, Ghervan L, Munteanu V, Moga S, Suciu M, et al. Ex-vivo perfusion machines in kidney transplantation. The significance of the resistivity index. Clujul Med. 2014;87:27–29. doi: 10.15386/cjm.2014.8872.871.fie1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Seiler S, Colbus MS, Lucisano G, Rogacev KS, Gerhart MK, Ziegler M, et al. Ultrasound renal resistive index is not an organ-specific predictor of allograft outcome. Nephrol Dial Transplant. 2012;27:3315–3320. doi: 10.1093/ndt/gfr805. [DOI] [PubMed] [Google Scholar]
  • 32.Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens. 2014;32:149–153. doi: 10.1097/HJH.0b013e328365b29c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int. 2005;68:878–885. doi: 10.1111/j.1523-1755.2005.00470.x. [DOI] [PubMed] [Google Scholar]
  • 34.Piscaglia F, Bolondi L Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32:1369–1375. doi: 10.1016/j.ultrasmedbio.2006.05.031. [DOI] [PubMed] [Google Scholar]
  • 35.Cokkinos DD, Antypa EG, Skilakaki M, Kriketou D, Tavernaraki E, Piperopoulos PN. Contrast enhanced ultrasound of the kidneys: what is it capable of? Biomed Res Int. 2013;2013 doi: 10.1155/2013/595873. 595873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.European Medicine Agency. 2017. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Summary_for_the_public/human/000303/WC500055374.pdf.
  • 37.Tranquart F, Mercier L, Frinking P, Gaud E, Arditi M. Perfusion quantification in contrast-enhanced ultrasound (CEUS)--ready for research projects and routine clinical use. Ultraschall Med. 2012;33(Suppl 1):S31–S38. doi: 10.1055/s-0032-1312894. [DOI] [PubMed] [Google Scholar]
  • 38.Sidhu P, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) Ultraschall Med. 2018;39:e2–e44. doi: 10.1055/a-0586-1107. [DOI] [PubMed] [Google Scholar]
  • 39.Farina R, Pennisi F, La Rosa M, Puglisi C, Di Benedetto A, Campisi G, et al. Functional study of the transplanted kidney with power Doppler US and time/intensity curves. Radiol Med. 2007;112:64–73. doi: 10.1007/s11547-007-0121-0. [DOI] [PubMed] [Google Scholar]
  • 40.Wang X, Yu Z, Guo R, Yin H, Hu X. Assessment of postoperative perfusion with contrast-enhanced ultrasonography in kidney transplantation. Int J Clin Exp Med. 2015;8:18399–18405. [PMC free article] [PubMed] [Google Scholar]
  • 41.Harvey CJ, Sidhu PS, Bachmann Nielsen M. Contrast-enhanced ultrasound in renal transplant: application and future directions. Ultraschall Med. 2013;34:319–321. doi: 10.1055/s-0033-1350138. [DOI] [PubMed] [Google Scholar]
  • 42.Fischer T, Mühler M, Kröncke TJ, Lembcke A, Rudolph J, Diekmann F, et al. Early postoperative ultrasound of kidney transplants: evaluation of contrast medium dynamics using time-intensity curves. Rofo. 2004;176:472–477. doi: 10.1055/s-2004-812992. [DOI] [PubMed] [Google Scholar]
  • 43.Grzelak P, Szymczyk K, Strzelczyk J, Kurnatowska I, Sapieha M, Nowicki M, et al. Perfusion of kidney graft pyramids and cortex in contrast-enhanced ultrasonography in the determination of the cause of delayed graft function. Ann Transplant. 2011;16:48–53. [PubMed] [Google Scholar]
  • 44.Fischer T, Dieckhöfer J, Mühler M, Lembcke A, Morgera S, Budde K, et al. The use of contrast-enhanced US in renal transplant: first results and potential clinical benefit. Eur Radiol. 2005;15(Suppl 5):E109–E116. doi: 10.1007/s10406-005-0173-y. [DOI] [PubMed] [Google Scholar]
  • 45.Fischer T, Filimonow S, Dieckhöfer J, Slowinski T, Mühler M, Lembcke A, et al. Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer--a new method for the diagnosis of renal perfusion. Nephrol Dial Treansplant. 2006;21:2921–2929. doi: 10.1093/ndt/gfl313. [DOI] [PubMed] [Google Scholar]
  • 46.Fischer T, Filimonow S, Rudolph J, Morgera S, Budde K, Slowinski T, et al. Arrival time parametric imaging: a new ultrasound technique for quantifying perfusion of kidney grafts. Ultraschall Med. 2008;29:418–423. doi: 10.1055/s-2006-927269. [DOI] [PubMed] [Google Scholar]
  • 47.Bennozzi L, Cappelli G, Granito M, Davoli D, Favali D, Montecchi MG, et al. Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc. 2009;41:1214–1215. doi: 10.1016/j.transproceed.2009.03.029. [DOI] [PubMed] [Google Scholar]
  • 48.Jin Y, Yang C, Wu S, Zhou S, Ji Z, Zhu T, et al. A novel simple noninvasive index to predict renal transplant acute rejection by contrast–enhanced ultrasonography. Transplantation. 2015;99:636–641. doi: 10.1097/TP.0000000000000382. [DOI] [PubMed] [Google Scholar]
  • 49.Fernandez PC, Ripolles T, Martinez MJ, Blay J, Pallardó L, Gavela E. Diagnosis of acute cortical necrosis in renal transplantation by contrast-enhanced ultrasound: a preliminary experience. Ultraschall Med. 2013;34:340–344. doi: 10.1055/s-0032-1313007. [DOI] [PubMed] [Google Scholar]
  • 50.Kay HD, Mazonakis M, Geddes C, Baxter G. Ultrasonic microbubble contrast agents and the transplant kidney. Clin Radiol. 2009;64:1081–1087. doi: 10.1016/j.crad.2009.06.010. [DOI] [PubMed] [Google Scholar]
  • 51.Schwenger V, Hankel V, Seckinger J, Macher-Göppinger S, Morath C, Zeisbrich M, et al. Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function. Transplant Proc. 2014;46:3352–3357. doi: 10.1016/j.transproceed.2014.04.013. [DOI] [PubMed] [Google Scholar]
  • 52.Mori G, Granito M, Favali D, Cappelli G. Long-term prognostic impact of contrast-enhanced ultrasound and power Doppler in renal transplantation. Transplant Proc. 2015;47:2139–2141. doi: 10.1016/j.transproceed.2014.11.080. [DOI] [PubMed] [Google Scholar]
  • 53.Stenberg B, Wilkinson M, Elliott S, Caplan N. The prevalence and significance of renal perfusion defects in early kidney transplants quantified using 3D contrast enhanced ultrasound (CEUS) Eur Radiol. 2017;27:4525–4531. doi: 10.1007/s00330-017-4871-3. [DOI] [PubMed] [Google Scholar]
  • 54.Mueller-Peltzer K, Negrão de Figueiredo G, Fischereder M, Habicht A, Rübenthaler J, Clevert DA. Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy. Clin Hemorheol Microcirc. 2018;69:77–82. doi: 10.3233/CH-189115. [DOI] [PubMed] [Google Scholar]
  • 55.Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34:11–29. doi: 10.1055/s-0032-1325499. [DOI] [PubMed] [Google Scholar]
  • 56.Sis B, Sarioglu S, Celik A, Kasap B, Yildiz S, Kavukcu S, et al. Renal medullary changes in renal allograft recipients with raised serum creatinine. J Clin Pathol. 2006;59:377–381. doi: 10.1136/jcp.2005.029181. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine and Pharmacy Reports are provided here courtesy of University of Medicine and Pharmacy of Cluj-Napoca, Romania

RESOURCES